Recruiting for Protocols Where Almost Nobody Qualifies
Tight inclusion criteria make volume-based outreach wasteful. Here's how to translate a restrictive protocol into findable criteria, search records before buying ads, and protect scarce eligible candidates through screening.
By Trialflow Team
Some protocols are written so tightly that broad outreach is actively wasteful. A narrow-window biomarker requirement, a specific prior-therapy sequence, a lab value that has to be captured inside a 14-day window — these protocols punish the advertising-first instinct. You spend money generating volume, then burn coordinator hours disqualifying almost all of it.
Narrow-eligibility studies need a different operating model: find fewer people, but find the right ones, and protect them through a longer screening path.
Start by translating the protocol into findable criteria
Most inclusion/exclusion lists mix two very different things: criteria you can identify in advance from existing records, and criteria you can only confirm during screening. Separate them explicitly before you do anything else.
For each criterion, write down where that information lives. Diagnosis code in the EHR? Medication list? Pathology report free text? A lab value nobody orders routinely? The criteria you can query become your search strategy. The criteria you cannot become your screening risk — the places candidates will fall out no matter how good your outreach is.
This exercise usually reveals that two or three criteria are doing almost all the filtering. Build your whole approach around those.
Search records before you buy attention
For tight protocols, chart review and EHR queries almost always outperform paid media on cost per randomization. A query that returns 60 charts with the right diagnosis and the right treatment history is more valuable than 600 form fills from people who saw an ad.
Practical steps:
- Ask your IT or informatics contact for a structured query on the one or two hard criteria, not the full I/E list. Over-specifying the query hides eligible patients behind incomplete coding.
- Review the returned list manually. Structured data will misclassify; free-text notes often hold the deciding detail.
- Keep a running internal registry of patients who narrowly missed prior studies with similar criteria. These people are the first call on the next narrow protocol.
Lean on referring clinicians, specifically
Generic "send us referrals" outreach produces generic referrals. For narrow studies, go to the specific clinicians who see the exact phenotype and give them a one-page, criteria-forward summary — the two or three things that matter, the window, and a direct contact. Make it easy enough that a referral takes under two minutes.
Follow up on every referral with feedback. Clinicians who hear what happened to the patient they sent will send more.
Design screening to lose fewer qualified people
When eligible candidates are scarce, every avoidable dropout hurts disproportionately. Sites commonly find their biggest losses are logistical, not medical.
- Pre-confirm the hard criteria before the visit. Get the pathology report, the prior-therapy documentation, or the imaging in hand. Do not spend a screening visit discovering something a records request would have answered.
- Shorten the gap between contact and screening. Scarce candidates often have active disease and competing options.
- Assign a named coordinator per candidate. Handoffs between staff cause more loss than most sites realize.
- Cover the friction. Travel, parking, scheduling around work. The cost is trivial next to a lost randomization.
Set expectations with the sponsor early
If your feasibility review suggests the eligible pool is small, say so before signing. Negotiate a realistic target, ask about protocol amendments under consideration, and ask whether other sites are hitting the same wall. Sponsors respect a site that forecasts accurately far more than one that overcommits and then goes quiet at month four.
Enrolling studies shouldn't be this hard
Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.
Request a Demo